Alkermes Wide Awake To Blockbuster Narcolepsy Market Potential

Having spun out its oncology business and put all of its eggs into a neuroscience-shaped basket, how is Alkermes executing on its 2024 stated strategy to return to its CNS roots?

(Shutterstock)

More from C-Suite Speaks

More from Innovation